文献速递肿瘤 PET/CT

基于临床生物学特征联合18F-FDG PET/CT影像组学的机器学习模型鉴别肺鳞癌与腺癌

Machine learning based on clinico-biological features integrated 18F-FDG PET/CT radiomics for distinguishing squamous cell carcinoma from adenocarcinoma of lung.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-10-15

本研究回顾性纳入315例经术后病理证实的非小细胞肺癌患者,随机分为训练集220例和验证集95例,利用LASSO回归基于临床因素、肿瘤标志物及PET/CT影像组学特征构建预测模型。由2个临床因素、2个肿瘤标志物、7个PET影像组学及3个CT影像组学参数组成的联合模型预测效能最高,训练集和验证集AUC分别为0.932(95%CI 0.900-0.964)和0.901(95%CI 0.840-0.957),并据此构建了校准良好的列线图。

要点

  • 联合临床、肿瘤标志物及PET/CT影像组学的列线图可无创鉴别NSCLC的鳞癌与腺癌。
  • 联合模型在训练集和验证集的AUC分别为0.932和0.901,优于单一参数模型。
  • 校准曲线显示列线图预测与实际观察一致性良好。

核心结论

  • 基于临床生物学特征联合18F-FDG PET/CT影像组学的列线图可准确、无创地个体化鉴别非小细胞肺癌的鳞癌与腺癌,辅助精准治疗决策。

研究设计与样本

  • 回顾性分析2017年1月至2019年6月经术后病理证实的315例NSCLC患者,随机分为训练集220例和验证集95例。
  • 分析术前临床因素、血清肿瘤标志物及PET和CT影像组学特征,采用LASSO回归构建预测模型。
  • 通过AUC和DeLong检验比较模型性能,决策曲线分析评估临床效用,并构建和验证列线图。

主要发现

  • 共纳入122例鳞癌和193例腺癌患者。
  • 分别构建了基于临床因素-肿瘤标志物、PET影像组学、CT影像组学及其组合的四个独立预测模型。
  • 联合模型由2个临床因素、2个肿瘤标志物、7个PET影像组学参数和3个CT影像组学参数组成,在训练集和验证集中预测效能和临床效用最高,AUC(95%CI)分别为0.932(0.900-0.964)和0.901(0.840-0.957)(p < 0.05)。
  • 基于联合模型的独立危险因素构建了定量列线图,校准曲线显示预测与实际观察一致性良好。

关键数值与推荐

  • 联合模型训练集AUC(95%CI)为0.932(0.900-0.964),验证集为0.901(0.840-0.957)。
  • 联合模型包含2个临床因素、2个肿瘤标志物、7个PET影像组学参数和3个CT影像组学参数。
  • DeLong检验和决策曲线分析显示联合模型预测效能和临床效用优于单一参数模型(p < 0.05)。

临床怎么用

  • 治疗前可利用该列线图无创鉴别NSCLC的鳞癌与腺癌,辅助临床决策。

局限性

  • 本研究为回顾性分析,样本来自单中心术后病理证实患者,需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop and validate a clinico-biological features and 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) radiomic-based nomogram via machine learning for the pretherapy prediction of discriminating between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) in non-small cell lung cancer (NSCLC). METHODS: A total of 315 NSCLC patients confirmed by postoperative pathology between January 2017 and June 2019 were retrospectively analyzed and randomly divided into the training (n = 220) and validation (n = 95) sets. Preoperative clinical factors, serum tumor markers, and PET, and CT radiomic features were analyzed. Prediction models were developed using the least absolute shrinkage and selection operator (LASSO) regression analysis. The performance of the models was evaluated and compared by the area under receiver-operator characteristic (ROC) curve (AUC) and DeLong test. The clinical utility of the models was determined via decision curve analysis (DCA). Then, a nomogram was developed based on the model with the best predictive efficiency and clinical utility and was validated using the calibration plots. RESULTS: In total, 122 SCC and 193 ADC patients were enrolled in this study. Four independent prediction models were separately developed to differentiate SCC from ADC using clinical factors-tumor markers, PET radiomics, CT radiomics, and their combination. The DeLong test and DCA showed that the Combined Model, consisting of 2 clinical factors, 2 tumor markers, 7 PET radiomics, and 3 CT radiomic parameters, held the highest predictive efficiency and clinical utility in predicting the NSCLC subtypes compared with the use of these parameters alone in both the training and validation sets (AUCs (95% CIs) = 0.932 (0.900-0.964), 0.901 (0.840-0.957), respectively) (p < 0.05). A quantitative nomogram was subsequently constructed using the independently risk factors from the Combined Model. The calibration curves indicated a good consistency between the actual observations and nomogram predictions. CONCLUSION: This study presents an integrated clinico-biologico-radiological nomogram that can be accurately and noninvasively used for the individualized differentiation SCC from ADC in NSCLC, thereby assisting in clinical decision making for precision treatment.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ren C, Zhang J, Qi M, et al. Machine learning based on clinico-biological features integrated 18F-FDG PET/CT radiomics for distinguishing squamous cell carcinoma from adenocarcinoma of lung. Eur J Nucl Med Mol Imaging. 2020. PMID: 33057772. doi:10.1007/s00259-020-05065-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。